Medical management of brain metastases.

Adam Lauko; Yasmeen Rauf; Manmeet S Ahluwalia

doi:10.1093/NOAJNL/VDAA015

Medical management of brain metastases.

Adam Lauko
, Yasmeen Rauf
, Manmeet S Ahluwalia

Herbert Wertheim Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-Oncology Advances
Volume	2
DOIs	https://doi.org/10.1093/NOAJNL/VDAA015
State	Published - Jan 1 2020

Disciplines

Medicine and Health Sciences
Critical Care

Access to Document

10.1093/NOAJNL/VDAA015License: Unspecified

Cite this

@article{270b7ee8a8454bccb37747b185afe884,

title = "Medical management of brain metastases.",

author = "Adam Lauko and Yasmeen Rauf and Ahluwalia, \{Manmeet S\}",

note = "The development of brain metastases occurs in 10-20\% of all patients with cancer. Brain metastases portend poor survival and contribute to increased cancer mortality and morbidity. Despite multimodal treatment options, which include surgery, radiotherapy, and chemotherapy, 5-year survival remains low.",

year = "2020",

month = jan,

day = "1",

doi = "10.1093/NOAJNL/VDAA015",

language = "American English",

volume = "2",

journal = "Neuro-Oncology Advances",

}

TY - JOUR

T1 - Medical management of brain metastases.

AU - Lauko, Adam

AU - Rauf, Yasmeen

AU - Ahluwalia, Manmeet S

N1 - The development of brain metastases occurs in 10-20% of all patients with cancer. Brain metastases portend poor survival and contribute to increased cancer mortality and morbidity. Despite multimodal treatment options, which include surgery, radiotherapy, and chemotherapy, 5-year survival remains low.

PY - 2020/1/1

Y1 - 2020/1/1

UR - https://academic.oup.com/noa/article/2/1/vdaa015/5890144

U2 - 10.1093/NOAJNL/VDAA015

DO - 10.1093/NOAJNL/VDAA015

M3 - Article

VL - 2

JO - Neuro-Oncology Advances

JF - Neuro-Oncology Advances

ER -

Medical management of brain metastases.

Disciplines

Access to Document

Other files and links

Cite this